Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide and Hepatic dysfunction
Result of checking the interaction of drug Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide and disease Hepatic dysfunction for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of elvitegravir is not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C). No dosage adjustment is required in patients with mild (Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment.
Generic Name: cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide
Brand Name: Genvoya, Stribild
Synonyms: n.a.
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - zaburzenia czynności wątroby 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - disfunção hepática 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - disfungsi hepatik 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - disfungsi hati 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - disfunzione epatica 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - dysfonctionnement hépatique 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - Leberfunktionsstörung 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - disfunción hepática 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - печеночная дисфункция 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - hepatik disfonksiyon 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - ضعف الكبد 
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - 肝功能障碍